Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-4465

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label of Oxcarbazepine 600 mg film-coated tablets, with a quantity of 30 tablets. The label includes the product name, strength, and quantity, along with manufacturer and repackager details: RemedyRepack Inc., Indiana, PA, and Breckenridge, Boca Raton, FL. Storage instructions and warnings to keep out of reach of children are also visible.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing a central seven-membered ring with a keto group, an amide substituent, and two fused benzene rings.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier plot showing exit rate over time from day 2 to day 11 in a clinical trial. The graph compares two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The vertical axis shows exit rate from 0 to 1, and the horizontal axis shows time on trial in days. A log-rank test p-value of 0.0001 is indicated, suggesting a statistically significant difference between the groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve showing seizure rate over days from first dose to first seizure. Two treatment groups are compared: Oxcarbazepine (solid line) and placebo (dotted line). The seizure rate increases over time, with the placebo group showing a higher seizure rate. A log-rank test p-value of 0.046 is displayed on the chart, indicating statistical comparison between groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier survival curve comparing exit rates over time in days between two treatment groups labeled HIGH (solid line) and LOW (dotted line). The vertical axis represents exit rate from 0.0 to 1.0, while the horizontal axis shows time to exit in days up to 130. The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison of the groups.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve chart showing exit rates over time in days for two treatment groups labeled 'HIGH' and 'LOW.' The y-axis represents exit rate from 0.0 to 1.0, and the x-axis shows time to exit up to 130 days. The dotted line (LOW group) shows a steeper increase compared to the solid line (HIGH group). A log-rank test p-value of 0.0001 is noted on the chart.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.